Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maher Hanoun

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|June 19, 2013
PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansionSandra Pinho, Julie Lacombe, Maher Hanoun, et al.
Blood Advances|July 3, 2020
Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitroJan Habbel, Lucas Arnold, Yiyang Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 12, 2019
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trialChristine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
Data in Brief|January 1, 2020
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationChristine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2020
Corrigendum to 'Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial' [Eur J Canc 124 (January 2020) 25-36]Christine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
Developmental Cell|May 15, 2014
Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow developmentToshihide Mizoguchi, Sandra Pinho, Jalal Ahmed, et al.
Scientific Reports|November 12, 2021
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosisMeike Farber, Yiyang Chen, Lucas Arnold, et al.
Cell Stem Cell|July 15, 2014
Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell nicheMaher Hanoun, Dachuan Zhang, Toshihide Mizoguchi, et al.
Plos One|April 4, 2012
Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemiaMaher Hanoun, Lewin Eisele, Masako Suzuki, et al.
European Journal of Haematology|June 23, 2011
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelSemra Aydin, Florian Grabellus, Lewin Eisele, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|June 19, 2013
PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansionSandra Pinho, Julie Lacombe, Maher Hanoun, et al.
Blood Advances|July 3, 2020
Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitroJan Habbel, Lucas Arnold, Yiyang Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 12, 2019
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trialChristine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
Data in Brief|January 1, 2020
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationChristine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2020
Corrigendum to 'Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial' [Eur J Canc 124 (January 2020) 25-36]Christine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
Developmental Cell|May 15, 2014
Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow developmentToshihide Mizoguchi, Sandra Pinho, Jalal Ahmed, et al.
Scientific Reports|November 12, 2021
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosisMeike Farber, Yiyang Chen, Lucas Arnold, et al.
Cell Stem Cell|July 15, 2014
Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell nicheMaher Hanoun, Dachuan Zhang, Toshihide Mizoguchi, et al.
Plos One|April 4, 2012
Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemiaMaher Hanoun, Lewin Eisele, Masako Suzuki, et al.
European Journal of Haematology|June 23, 2011
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelSemra Aydin, Florian Grabellus, Lewin Eisele, et al.
Pageof 6